Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo.
about
Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infantsErythropoietin and Neonatal NeuroprotectionRole of mitochondria in apoptotic and necroptotic cell death in the developing brainDarbepoetin Administration in Term and Preterm NeonatesNeuroprotective potential of erythropoietin in neonates; design of a randomized trial.Complex pattern of interaction between in utero hypoxia-ischemia and intra-amniotic inflammation disrupts brain development and motor function.High plasma erythropoietin levels are associated with prolonged coma duration and increased mortality in children with cerebral malaria.Elevated endogenous erythropoietin concentrations are associated with increased risk of brain damage in extremely preterm neonatesCongenital cardiac anomalies and white matter injuryPrenatal Hypoxia-Ischemia Induces Abnormalities in CA3 Microstructure, Potassium Chloride Co-Transporter 2 Expression and Inhibitory Tone.The role of inflammation in perinatal brain injury.Preschool Assessment of Preterm Infants Treated With Darbepoetin and ErythropoietinRecombinant human erythropoietin improves neurological outcomes in very preterm infants.Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.Erythropoietin: a novel therapy for hypoxic-ischaemic encephalopathy?Controversies in preterm brain injury.Darbepoetin administration to neonates undergoing cooling for encephalopathy: a safety and pharmacokinetic trial.Erythropoietin Restores Long-Term Neurocognitive Function Involving Mechanisms of Neuronal Plasticity in a Model of Hyperoxia-Induced Preterm Brain Injury.EV-3, an endogenous human erythropoietin isoform with distinct functional relevance.Erythropoiesis Stimulating Agents Demonstrate Safety and Show Promise as Neuroprotective Agents in Neonates.Why do four NICUs using identical RBC transfusion guidelines have different gestational age-adjusted RBC transfusion rates?Neuroimaging in former preterm children who received erythropoiesis stimulating agents.Early erythropoiesis-stimulating agents in preterm or low birth weight infants.Neonatal erythropoietin mitigates impaired gait, social interaction and diffusion tensor imaging abnormalities in a rat model of prenatal brain injury.The long-term effect of erythropoiesis stimulating agents given to preterm infants: a proton magnetic resonance spectroscopy study on neurometabolites in early childhood.Repetitive Neonatal Erythropoietin and Melatonin Combinatorial Treatment Provides Sustained Repair of Functional Deficits in a Rat Model of Cerebral Palsy.Extended Erythropoietin Treatment Prevents Chronic Executive Functional and Microstructural Deficits Following Early Severe Traumatic Brain Injury in Rats.Extended Combined Neonatal Treatment With Erythropoietin Plus Melatonin Prevents Posthemorrhagic Hydrocephalus of Prematurity in Rats
P2860
Q24195000-E5EBAD8F-23AA-48DC-B188-564CBFE553ABQ27009422-2820FBD1-73ED-412F-9E7A-7DE7918DE3A1Q28083288-9F8950D8-8ADD-41F2-9698-7F521088FD4EQ28085116-BC212D55-063C-486C-A893-21EBD8B3589DQ31071784-DD569DDD-6EA1-4210-8F5E-55C088C9E0B2Q34026944-3837DE1D-14FE-4450-9F6A-0F592B3EF1BDQ34974570-16917633-DC74-47C8-9FE6-1EA1A7C8ED81Q35202607-97166CF2-6A6E-4815-8073-0EA486C776FAQ35706661-36C0EC5B-1C7F-4D1D-9671-B30F67D7986DQ36022351-2F8F6297-8402-45A1-AFF0-73E36FE7380DQ36331560-53FF159F-F44A-4714-9CDB-EC9237557189Q36630778-C5562594-F5FF-4DF9-9117-38BD71FDC49DQ37375616-C811B85E-7D28-4F6C-9F6F-C41E00D73EA3Q37724782-84B386CA-1308-4B18-9D3C-D67394043808Q38387887-9653E34B-CAF4-4A23-9D21-6EFDAD5156B0Q38610168-E895A33F-4E81-453F-9A2A-0502FCF10BEEQ41469526-EAD48B61-5FAB-4BB6-AC65-E584F0ABD737Q41775024-0968D662-190A-4C6D-A659-75D0BB905877Q42003728-6AEF9316-0444-4310-AE1A-B5C08A4E262CQ42949621-C9341820-6C7E-4EC4-B904-48F4FA6FFBF6Q44919040-7DAAD4C0-E779-4355-952E-13CF6F7FC30BQ47134409-1D58E0E7-645A-4BAF-A054-DE5F9168E07DQ47176323-9B47749B-7CF3-406E-B560-ED83F15E3F95Q47216442-6BC27CFB-2259-4131-BFC7-083C53198765Q47863360-1023879F-314F-4152-B3B1-C36517B1C588Q53828021-9326A4A1-58AB-403C-8671-DEDB41C440D7Q55413545-E0510597-9648-41A3-85E3-0E55B8709A6AQ57491952-E5C53AFD-B983-4672-AACA-C8547114CCCB
P2860
Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Cognitive outcomes of preterm ...... n, erythropoietin, or placebo.
@ast
Cognitive outcomes of preterm ...... n, erythropoietin, or placebo.
@en
type
label
Cognitive outcomes of preterm ...... n, erythropoietin, or placebo.
@ast
Cognitive outcomes of preterm ...... n, erythropoietin, or placebo.
@en
prefLabel
Cognitive outcomes of preterm ...... n, erythropoietin, or placebo.
@ast
Cognitive outcomes of preterm ...... n, erythropoietin, or placebo.
@en
P2093
P2860
P921
P356
P1433
P1476
Cognitive outcomes of preterm ...... n, erythropoietin, or placebo.
@en
P2093
Adam Rosenberg
Barbara Pruckler
Conra Backstrom Lacy
Daniel C Cannon
Diane K Lambert
Hannah Peceny
Janell Fuller
Jean R Lowe
Jill J Burnett
Mahshid Roohi
P2860
P304
P356
10.1542/PEDS.2013-4307
P407
P577
2014-05-12T00:00:00Z